Catalog Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Cardiac Arrest (1762); Vasoconstriction (2126)
|
Event Date 10/31/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
E 1.Initial reporter phone (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) cardiac ablation procedure which included the use of a thermocool® smart touch® sf bi-directional navigation catheter and experienced coronary spasm treated with pericardiocentesis and hospitalization.After pulmonary vein isolation (pvi) and cavotricuspid isthmus (cti) ablation, the procedure was completed after confirming by intracardiac echocardiography (ice) that there was no effusion.Afterwards, decreased blood pressure and depressed level of consciousness were observed in the ward, so the patient was moved to the catheterization room urgently.Coronary angiography (cag) showed coronary spasm.Although drugs were administered, the spasm could not be completely removed, and percutaneous coronary intervention (pci) was performed to complete the procedure.A short time after the patient left the room, the patient was again found to have decreased blood pressure and decreased level of consciousness, and cardiopulmonary resuscitation (cpr) was started.Extracorporeal membrane oxygenation (ecmo) was inserted into the patient in the catheterization room and then the patient was transported to another hospital.The physician's opinion is no clear cause is known and the causal relationship is unknown.
|
|
Manufacturer Narrative
|
On 02-dec-2023, the product investigation was completed as the complaint device was not returned.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation (mre) was performed for the finished device 31122806l number, and no internal action related to the complaint was found during the review.Based on the completed mre, the manufactured date and expiration date have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated with appropriate information.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|